CCM2 and neuroblastoma: Additionally, Liraz Harel et al. have shown that CCM2 interacts with TrkA via its PTB domain and mediates TrkA-induced cell death through its Karet domain in neuroblastoma or medulloblastoma (Harel et al., 2009).